These data suggest that benralizumab may have the potential to improve symptoms and respiratory function in patients with severe eosinophilic asthma by reducing mucus plugs.
No takes yet. Share an insight, caveat, or question.
Sakai et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: